Avalo Therapeutics, Inc. Share Price & Technical Analysis
AVTX · $19.23 (-3.12%)
Healthcare / Biotechnology
$19.23
-3.12%
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Av…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
21% return in May, -18% avg return in past 3 year May month.
-11% return in 2026, 46% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -17% | 9% | -12% | -12% | 21% | – | – | – | – | – | – | – | -11% |
| 25 | 12% | -11% | 10% | -40% | -20% | 22% | 58% | 21% | 37% | 41% | 6% | -2% | 131% |
| 24 | -47% | -6% | 395% | -14% | -32% | 10% | -6% | -39% | 34% | 38% | -27% | -22% | 284% |
| 23 | -22% | -36% | -31% | 57% | -3% | -87% | -44% | -52% | 23% | -11% | -33% | -39% | -277% |
| 22 | -42% | -27% | -6% | -44% | -14% | 38% | -44% | 26% | -30% | 76% | -9% | -8% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.04B
P/E ratio
—
52W high
$24.27
52W low
$3.43
Volume
5,18,246
Beta
0.79
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Avalo Therapeutics, Inc. share price today?
- Avalo Therapeutics, Inc. (AVTX) last traded around $19.23 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AVTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AVTX. Download the app for real-time alerts.
- How can I analyze Avalo Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.